Aloe-emodin metabolites protected N-methyl-D-aspartate-treated retinal ganglion cells by Cu-Zn superoxide dismutase

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 2, 2007, Pages 152-171

  Lin, Hui Ju ^a,b   Lai, Chien Chen ^a,c   Chao, Pei Dawn Lee ^d   Fan, Seng Sheen ^b   Tsai, Yuhsin ^d   Huang, Shiuan Yi ^a   Wan, Lei ^a   Tsai, Fuu Jen ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE EMODIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ENERGY; CELL LEVEL; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; GLAUCOMA; LIQUID CHROMATOGRAPHY; MALE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; RAT; RETINA GANGLION CELL; RNA ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; APOPTOSIS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EMODIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLAUCOMA; GLUCURONIDES; GLUTAMIC ACID; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; POLYMERASE CHAIN REACTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL GANGLION CELLS; RNA, MESSENGER; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFATES; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 34247354884     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.0118     Document Type: Article

References (46)

1. Wolfs, R.C., Borger, P.H., Ramrattan, R.S., et al. Changing views on open-angle glaucoma: Definitions and prevalences. Invest. Ophthalmol. Vis. Sci. 41:3309-3321, 2000.
2. Klemett, A. Low-tension glaucoma - a disease for ophthalmology or internal medicine? Duodecim. 113:1425-1426, 1997.
3. Koss, M.C. Functional role of nitric oxide in regulation of ocular blood flow. Eur. J. Pharmacol. 374:161-174, 1999.
4. Garcia-Valenzuela, E., Shareef, S., Walsh, J., et al. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 61:33-44, 1995.
5. Dreyer, E.B., and Grosskreutz, C.L. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG). Clin. Neurosci. 4:270-273, 1997.
6. Hauben, E., Nevo, U., Yoles, E., et al. Autoimmune T-cells as potential neuroprotective therapy for spinal cord injury. Lancet 355:286-287, 2000.
7. Moalem, G., Leibowitz-Amit, R., Yoles, E., et al. Autoimmune T-cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:49-55, 1999.
8. Schori, H., Yoles, E., and Schwartz, M. T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system. J. Neuroimmunol. 119:199-204, 2001.
9. Schwartz, M., and Kipnis, J.G. Genetic control of immune response to trauma: Vaccination for acute and chronic CNS degenerative disorders. Trends Mol. Med. 7:252-258, 2001.
10. Bakalash, S., Kessler, A., Mizrahi, T., et al. Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest. Ophthalmol. Vis. Sci. 44:3374-3381, 2003.
11. Lipton, S.A., and Rosenberg, R.A. Mechanisms of disease: Excitatory amino acids as a final common pathway in neurologic disorders. N. Engl. J. Med. 330:613-622, 1994.
12. Kaul, M., Garden, G.A., and Lipton, S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994, 2001.
13. Nucci, C., Tartaglione, R., Rombola, L., et al. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26:935-941, 2005.
14. Luo, X., Heidinger, V., Picaud, S., et al. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest. Ophthalmol. Vis. Sci. 42:1096-1106, 2001.
15. Kido, N., Tanihara, H., Honjo, M., et al. Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death. Brain Res. 884:59-67, 2000.
16. Dreyer, E.B., Zurakowski, D., Schumer, R.A., et al. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114:299-305, 1996.
17. Brooks, D.E., Garcia, G.A., Dreyer, E.B., et al. Vitreous body glutamate concentration in dogs with glaucoma. Am. J. Vet. Res. 58:864-867, 1997.
18. Sucher, N.J., Aizenman, E., and Lipton, S.A. N-methyl-D- aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J. Neurosci. 11:966-971, 1991.
19. 2+ block of the N-methyl-D- aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Neurochem. 59:1211-1120, 1992.
20. Yoles, E., and Schwartz, M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch. Ophthalmol. 116:906-910, 1998.
21. Yoles, E., and Schwartz, M. Degeneration of spared axons following partial white matter lesion: Implications for optic nerve neuropathies. Exp. Neurol. 153:1-7, 1998.
22. Neacsu, A., Oprean, C., Curea, M., et al. Neuroprotection with carotenoids in glaucoma. Oftalmologia 59:70-75, 2003.
23. Ferreira, S.M., Lerner, S.F., Brunzini, R., et al. Oxidative stress markers in aqueous humor of glaucoma patients. Am. J. Ophthalmol. 137:62-69, 2004.
24. Kang, J.H., Pasquale, L.R., Willett, W., et al. Antioxidant intake and primary open-angle glaucoma: A prospective study. Am. J. Epidemiol. 158:337-346, 2003.
25. Gu, J.W., Hasuo, H., Takeya, M., et al. Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitro. Neuropharmacology 49:103-111, 2005.
26. Mijatovic, S., Maksimovic-Ivanic, D., Radovic, J., et al. Aloe-emodin prevents cytokine-induced tumor cell death: The inhibition of autotoxic nitric oxide release as a potential mechanism. Cell Mol. Life Sci. 6:1805-1815, 2004.
27. Lee, H.Z., Wu, C.H., and Chang, S.P. Release of nucleophosmin from the nucleus: Involvement in aloe-emodin-induced human lung non-small-carcinoma cell apoptosis. Int. J. Cancer 113:971-976, 2005.
28. Lee, H.Z., Hsu, S.L., Liu, M.C., et al. Effects and mechanisms of aloe-emodin on cell death in human lung squamous-cell carcinoma. Eur. J. Pharmacol. 431:287-295, 2001.
29. Olthof, M.R., Hollman, P.C., Vree, T.B., et al. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in human. J. Nutr. 130:1200-1203, 2000.
30. Hsiu, S.L., Huang, T.Y., Hou, Y.C., et al. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci. 70:1481-1489, 2002.
31. Fang, S.H., Hou, Y.C., Chang, W.C., et al. Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci. 74:743-756, 2003.
32. Futcher, B., Latter, G.I., Monardo, P., et al. A sampling of the yeast proteome. Mol. Cell Biol. 19:7357-7368, 1999.
33. Griffin, T.J., Gygi, S.P., Ideker, T., et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell Prot. 1:323-333, 2002.
34. Terry, D.E., Umstot, E., and Desiderio, D.M. Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests. J. Am. Soc. Mass Spect. 15:784-794, 2004.
35. Hirosawa, M., Hoshida, M., Ishikawa, M., et al. MASCOT: Multiple alignment system for protein sequences based on three-way programming. Comput. Appl. Biosci. 9:161-167, 1993.
36. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408, 2001.
37. Glimann, C, Sheehan, K., Kay, E., et al. Array-based proteomics: Mapping of protein circuitries for diagnostics, and therapy guidance in cancer. J. Pathol. 208:595-606, 2006.
38. Witt, A.E., Hines, L.M., Collins, N.L., et al. Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. J. Prot. Res. 5:599-610, 2006.
39. Lovegrove, C. Galectin-1: A novel hypoxia-induced protein linked with tumor immune privilege. Nat. Clin. Pract. Oncol. 3:6, 2006.
40. Tomlinson, V.A., Newbery, H.J., Wray, N.R., et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 5:113, 2005.
41. Rylander, M.N., Feng, Y., Bass, J., et al. Thermally induced injury and heat-shock protein expression in cells and tissues. Ann. N.Y. Acad. Sci. 1066:222-242, 2006.
42. Zhang, H.W., Wang, F.S., Shao, W., et al. Characterization and stability investigation of cu,zn-superoxide dismutase covalently modified by low-molecular-weight heparin. Biochemistry (Moscow). 71(Suppl. 1):S96-S100, 2006.
43. Okada, S.F., O'Neal, W.K., Huang, P., et al. Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell-volume regulation in murine cells. J. Gen. Physiol. 124:513-526, 2004.
44. Myung, J.K., Gulesserian, T., Fountoulakis, M., et al. Deranged hypothetical proteins Rik protein, Nit protein 2, and mitochondrial inner membrane protein, mitofilin, in fetal Down syndrome brain. Cell Mol. Biol. (Noisy-le-grand). 49:739-746, 2003.
45. Ciaffi, M., Paolacci, A.R., D'Aloisio, E., et al. Cloning and characterization of wheat PDI (protein disulfide isomerase) homoeologous genes and promoter sequences. Gene 366(1):209-218, 2006.
46. Ben Simon, G., Bakalash, J., Aloni, E.S., et al. A rat model for acute rise in intraocular pressure: Immune modulation as a therapeutic strategy. Am. J. Ophthalmol. 141:1105-1111, 2006.